Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for ...
Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for myotonic dystrophy type 1 (DM1), the most common adult-onset form of ...
The technology, called the Viral-Engineered RNA-based Activation System (VERAS), hijacks the virus's own replication ...
Mounting evidence from research on nematodes to mice indicate that a father's environment, such as what he eats or if he is ...
Molecular mechanism uncovered in mice by UC Santa Cruz researchers reveals how a father’s diet, stress, and other ...
Korro Bio, Inc. ( KRRO) 44th Annual J.P. Morgan Healthcare Conference January 15, 2026 1:30 PM EST ...
AZoLifeSciences on MSN
Synthetic RNA platform converts viral replication into detectable cellular signals
The technology, called the Viral-Engineered RNA-based Activation System (VERAS), hijacks the virus's own replication ...
Nucleosomes are barriers to RNA Polymerase II (Pol II) transcribing along gene bodies in eukaryotes. We found that a fragile “tailless nucleosome” could be generated to resolve the Pol II pausing ...
A research team has uncovered and reconstructed the complete biosynthetic pathway of polyphyllin II—a potent anticancer ...
As genetic engineering technologies such as clustered regularly interspaced short palindromic repeats (CRISPR) improve and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback